Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Fatal liaisons of p53 with Bax and Bak — Jean‐Luc Perfettini (2004) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Fatal liaisons of p53 with Bax and Bak
Shared by
Guido Guido Kroemer
Fatal liaisons of p53 with Bax and Bak
Letter
2004
en
Authors
JP
Jean‐Luc Perfettini
RK
Romano T. Kroemer
Guido Guido Kroemer
Related publications
Article
2010
Mitochondrial Liaisons of p53
Lorenzo Galluzzi
,
Eugenia Morselli
,
Oliver Kepp
,
Ilio Vitale
,
Marcello Pinti
,
Guido Guido Kroemer
Article
2021
Paradoxical implication of BAX/BAK in the persistence of tetraploid cells
Jiayin Deng
,
Lucía G. Gutiérrez
,
Gautier Stoll
,
Omar Motiño
,
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Isabelle Martins
,
Lucı́a Núñez
,
José Manuel Bravo‐San Pedro
,
Juliette Humeau
,
Chloé Bordenave
,
Juncheng Pan
,
Hélène Fohrer-Ting
,
Sylvie Souquère
,
Gérard Pierron
,
Claudio Hetz
,
Carlos Villalobos
,
Guido Guido Kroemer
,
Laura Senovilla
Article
2008
Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell death
Nicolas Tajeddine
,
Lorenzo Galluzzi
,
Oliver Kepp
,
Emilie Hangen
,
Eugenia Morselli
,
Laura Senovilla
,
Natália de Souza Araujo
,
Guillaume Pinna
,
Nathanaël Larochette
,
Naoufal Zamzami
,
Nazanine Modjtahedi
,
Annick Harel‐Bellan
,
Guido Guido Kroemer
Article
2015
The oncolytic peptide LTX-315 kills cancer cells through Bax/Bak-regulated mitochondrial membrane permeabilization
Heng Zhou
,
Sabrina Forveille
,
Allan Sauvat
,
Valentina Sica
,
Valentina Izzo
,
Sylvère Durand
,
Kévin Müller
,
Peng Liu
,
Laurence Zitvogel
,
Øystein Rekdal
,
Oliver Kepp
,
Guido Guido Kroemer
Article
1998
Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease
Yoshihisa Kitamura
,
Shun Shimohama
,
Wataru Kamoshima
,
Takashi Ota
,
Yasuji Matsuoka
,
Yasuyuki Nomura
,
Mark A. Smith
,
George Perry
,
Peter J. Whitehouse
,
Takashi Taniguchi
Discussion(0)
No comments yet. Be the first to comment.